Hortifrut (HF-B) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Feb, 2026Executive summary
Revenue for the first half of 2024 reached $629.8 million, up from $502.9 million year-over-year, with gross profit at $96.2 million compared to $94.9 million in 2023.
Net income for the first half of 2024 was $20.2 million, down from $24.6 million in the same period last year.
The company remains a global leader in berries, with diversified operations across North America, Europe, Latin America, and Asia.
Financial highlights
Operating revenue increased 25% year-over-year for the first half of 2024.
Gross margin for the first half of 2024 was 15.3%, down from 18.9% in 2023.
EBITDA for the last twelve months was $180.5 million, with an adjusted net financial debt/EBITDA ratio of 3.2x.
Cash and cash equivalents as of June 30, 2024, were $59.1 million.
Total assets stood at $1.81 billion, with total equity of $739.5 million.
Outlook and guidance
Management expects operating cash flows and available liquidity to be sufficient for working capital and interest payments over the next 12 months.
The company continues to invest in global expansion, genetics, and sustainability initiatives.
Latest events from Hortifrut
- Q1 2026 saw stable revenue, higher net profit, and strong operating cash flow.HF-B
Q1 2026 - 2025 revenue rose 5.3% to $1,227M, but net loss deepened to $73.3M on higher impairments.HF-B
Q4 2025 - Revenue up 7% to US$1,026M; EBITDA +23%; net profit down 38% on asset impairments.HF-B
Q4 2023 - Revenue up, but net loss driven by asset impairments; liquidity remains strong.HF-B
Q3 2025 - H1 2025 saw $641.6M revenue, $75.4M net loss, and strong North American sales amid higher costs.HF-B
Q2 2025 - Net income rose 44% to $37.2M in Q1 2025, with improved margins and strong liquidity.HF-B
Q1 2025 - Revenue, net income, and cash flow rose as Hortifrut expanded globally and managed risks.HF-B
Q3 2024 - Revenue up 13.6% to $1.16B, but $41.2M net loss due to higher impairment and costs.HF-B
Q4 2024